EUDA Health (NASDAQ: EUDA) suspends ATM offering, files termination notice

Rhea-AI Filing Summary

EUDA Health Holdings filed a prospectus supplement to amend its prior ATM registration, reducing the maximum aggregate offering price to $10.0 million and suspending further sales under the ATM Agreement. The company states that no ordinary shares have been sold under the ATM Agreement as of the date of this Supplement. The company notified the manager on June 5, 2026 of its intent to terminate the ATM Agreement; the termination becomes effective 30 business days after that notice per the agreement. The supplement notes the Nasdaq closing price of the ordinary shares was $15.50 on June 11, 2026.

Insights

Equity Capital Markets Analyst

EUDA suspended and reduced its ATM capacity to zero and has initiated termination of the ATM Agreement.

The supplement amends prior prospectus supplements to set the ATM Offering maximum aggregate amount at $10.0 million and to suspend further sales; it also states no shares were sold under the agreement as of the supplement date. The filing preserves the contractual termination process, which becomes effective 30 business days after the June 5, 2026 notice.

Cash-flow treatment and use of proceeds are not described in this excerpt; subsequent prospectus filings will report the formal termination and any related administrative updates.

Key Figures

ATM capacity: $10.0 million Termination notice date: June 5, 2026 Termination effective period: 30 business days +1 more

4 metrics

ATM capacity $10.0 million maximum aggregate offering price under the ATM Agreement

Termination notice date June 5, 2026 date company sent notice to terminate the ATM Agreement

Termination effective period 30 business days effective period after termination notice per ATM Agreement

Nasdaq closing price $15.50 closing price of Ordinary Shares on Nasdaq on June 11, 2026

Key Terms

at-the-market Offering (ATM Offering), ATM Agreement, prospectus supplement

3 terms

at-the-market Offering (ATM Offering) financial

"to register the offer and sale of shares of our ordinary shares, having an aggregate offering price of up to $10.0 million in an “at-the-market” offering"

ATM Agreement regulatory

"pursuant to the At The Market Offering Agreement, dated June 23, 2025 (the “ATM Agreement”)"

An at-the-market (ATM) agreement lets a company sell newly issued shares directly into the public market over time through a broker, rather than selling a large block all at once. Investors care because it provides a flexible way for the company to raise cash when needed, but it can increase the number of shares outstanding gradually and put downward pressure on the stock price if sales are large relative to normal trading—similar to adding more product to a store shelf while customers are buying.

prospectus supplement regulatory

"This prospectus supplement (this “Supplement”) amends and supplements the prospectus dated November 4, 2024"

A prospectus supplement is an additional document provided alongside a company's main offering details, offering updated or extra information about a specific financial product being sold. It helps investors understand the latest terms, risks, and details of the investment, similar to how an update or revision clarifies or expands on original instructions, ensuring they have current and complete information before making a decision.

Offering Details

ATM

Offering

Offering Type ATM

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 06/11/2026 - 07:00 AM Accepted by SEC EDGAR 06/11/2026 - 07:00 AM Learn about SEC filing dates

FAQ

What did EUDA (EUDA) file in the June 11, 2026 prospectus supplement?

EUDA filed a supplement that amends prior ATM prospectus supplements and reduces the ATM Offering maximum aggregate amount to $10.0 million. It also suspends further sales under the ATM Agreement and reports no shares sold under that agreement as of the supplement date.

Has EUDA sold any shares under the ATM Agreement?

No. The prospectus supplement states no ordinary shares have been sold under the ATM Agreement or the Filed Prospectus Supplements as of the supplement date, June 11, 2026.

When did EUDA notify the manager about terminating the ATM Agreement?

EUDA sent the manager a termination notice on June 5, 2026. The filing states the termination becomes effective 30 business days from that notice under the ATM Agreement's terms.

What is the Nasdaq closing price disclosed in the supplement?

The supplement reports the company's ordinary shares closed on Nasdaq at $15.50 on June 11, 2026. This price is presented as a market reference only in the supplement.

Will EUDA file anything further about the ATM termination?

Yes. The supplement states the company will file a prospectus supplement to report the termination of the ATM Agreement and related prospectus supplements shortly after the termination's effective date, per the ATM Agreement.

Filed Pursuant to Rule 424(b)(5)

Registration No. 333-282723

PROSPECTUS SUPPLEMENT

(To Prospectus dated November 4, 2024)

EUDA HEALTH HOLDINGS LIMITED

This prospectus supplement (this “Supplement”) amends and supplements the prospectus dated November 4, 2024 (the “Base Prospectus”), as amended and supplemented by the Prospectus Supplement dated June 24, 2025 and January 23, 2026, (collectively, the “Filed Prospectus Supplements”). This Supplement is qualified in its entirety by reference to the Base Prospectus, as amended and supplemented to date, except to the extent that the information herein amends or supersedes the information contained therein.

We filed the Filed Prospectus Supplements to register the offer and sale of shares of our ordinary shares, having an aggregate offering price of up to $10.0 million in an “at-the-market” offering (the “ATM Offering”) pursuant to the At The Market Offering Agreement, dated June 23, 2025 (the “ATM Agreement”), with Chardan Capital Markets, LLC (the “Manager”). We are filing this Supplement to amend and supplement the information in the Filed Prospectus Supplements to suspend the ATM Offering and reduce the maximum aggregate offering price of our ordinary shares that may be offered and sold under the ATM Agreement from and after the date hereof to zero. As of the date of this Supplement, no ordinary shares have been sold under the ATM Agreement or the Filed Prospectus Supplements.

On June 5, 2026, we sent the Manager a notice to terminate the ATM Agreement and the ATM Offering. We will file a prospectus supplement to report the termination of the ATM Agreement and the ATM Offering, and to terminate all related prospectus supplements shortly after the effective date of the termination which is 30 business days from the date of the termination pursuant to the terms of the ATM Agreement.

Our Ordinary Shares are listed on the NASDAQ Capital Market under the symbol “EUDA”. On June 11, 2026, the closing price of our Ordinary Shares on the Nasdaq Capital Market was US$15.50.

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the accuracy or adequacy of this prospectus supplement. Any representation to the contrary is a criminal offense.

The date of this prospectus supplement is June 11, 2026.